Michael D. Miller

University of Connecticut — United States

Medicine · Health Sciences

115h-index79.6kcitations576works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(238), HIV Research and Treatment(214), HIV/AIDS Research and Interventions(180), HIV, Drug Use, Sexual Risk(66), Hepatitis C virus research(63)

Publications572 total

Prevalence of HIV, syphilis, and condomless sex among MSM in Nepal; findings based on an integrated biological and behavioral surveillance survey using respondent-driven sampling
Medicine·2025Open Access
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
UNC Libraries·2025Open Access
Prevalence and determinants of excessive daytime sleepiness among men who have sex with men in Nepal: A cross-sectional study
Medicine·2025Open Access
Do we need routine integrase resistance testing before starting antiretroviral therapy?
The Lancet HIV·2025· 1 citedOpen Access
An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction
Neuropsychiatric Disease and Treatment·2025Open Access
Non-fatal Overdose and Associated Factors Among People Who Use Opioids: Findings From a Cross-sectional Study
Journal of Community Health·2025· 2 cited
Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention
Journal of Substance Use and Addiction Treatment·2025· 1 citedOpen Access
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRECT: A Mixed Methods Study
AIDS and Behavior·2025
Unraveling HIV Risk and Prevention Among Female Sex Workers in Uganda: Insights From Focus Group Discussions
Drug and Alcohol Dependence·2025
Testing the feasibility, acceptability, and preliminary efficacy of integrating accommodation strategies into an HIV prevention intervention for people who inject drugs with cognitive dysfunction
Journal of Substance Use and Addiction Treatment·2024Open Access
Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial
PLoS ONE·2024· 2 citedOpen Access
Examining the Accuracy of Self-Reported Antiretroviral Therapy Adherence Using a Visual Analog Scale Among Opioid-Dependent People Living with HIV
AIDS and Behavior·2024
IMPACT OF IMPAIRED COGNITIVE FUNCTIONING AMONG PERSONS ON MEDICATION FOR OPIOID USE DISORDER
Drug and Alcohol Dependence·2024
Application of the Multiphase Optimization Strategy (MOST) to Optimize HIV Prevention Targeting People on Medication for Opioid Use Disorder (MOUD) who Have Cognitive Dysfunction: A Study Protocol
Drug and Alcohol Dependence·2024
Examining HIV Knowledge and Sexually Risky Behaviors among Female Sex Workers in Kampala, Uganda
International Journal of Environmental Research and Public Health·2024· 6 citedOpen Access
365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment
Open Forum Infectious Diseases·2023Open Access
Examining HIV Knowledge and Sexual Risky Behaviors Among Female Sex Workers in Kampala, Uganda
Preprints.org·2023· 2 citedOpen Access
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study
HIV Medicine·2023· 5 citedOpen Access
34 Using Spatial Analysis to Identify Access to IFHP-registered Paediatric Providers in Ontario
Paediatrics & Child Health·2023Open Access
Application of the multiphase optimisation strategy (MOST) to optimise HIV prevention targeting people on medication for opioid use disorder (MOUD) who have cognitive dysfunction: protocol for a MOST study
BMJ Open·2023· 2 citedOpen Access
page 1 of 29Next →

Frequent Co-authors

Ole Buchardt(10), Jason P. Affourtit(8), Jan Fredrik Simons(8), Peter E. Nielsen(8), Jonathan M. Rothberg(7), Rolf H. Berg(7), Brian Desany(6), Richard A. Gibbs(5), Stephen Hutchison(5), Daria J. Hazuda(5), Andrew G. Clark(5), Lei Du(4), M. T. Ronan(4), Jun Wang(4), Faheem Niazi(4), Leif Christensen(4), Gustavo Palacios(4), Thomas Briese(4), W. Ian Lipkin(4), Mark J. DiNubile(4)